Iceland vs Norway: Avoidable mortality
Avoidable mortality over time
- Iceland
- Norway
How they compare
Norway currently reports 8,381 Deaths against 541 Deaths in Iceland, a difference of 7,840 Deaths.
That makes Norway's figure about 15.5 times Iceland's.
Across all 17 years both countries report, Norway has been ahead every year.
Iceland ranks 36th and Norway ranks 34th of 36 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iceland | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 471.5 Deaths | 8,960 Deaths | 8,488 Deaths | Norway |
| 2010s | 447.86 Deaths | 8,365 Deaths | 7,917 Deaths | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher avoidable mortality, Iceland or Norway?
- Norway, at 8,381 Deaths against 541 Deaths in Iceland as of 2016.
- What is the difference in avoidable mortality between Iceland and Norway?
- 7,840 Deaths, with Norway ahead.
- How many years of comparable data are there for Iceland and Norway?
- 17 years are reported by both, from 2000 to 2016.
- How do Iceland and Norway rank globally for avoidable mortality?
- Iceland ranks 36th and Norway ranks 34th of 36 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Avoidable mortality. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents data on preventable, treatable and avoidable (preventable + treatable) causes of mortality. Preventable and treatable causes of mortality are defined as follows: - Preventable mortality: Causes of death that can be mainly avoided through effective public health and primary prevention interventions (i.e. before the onset of diseases/injuries, to reduce incidence). - Treatable (or amenable) mortality: Causes of death that can be mainly avoided through timely and effective healthcare interventions, including secondary prevention such as screening, and treatment (i.e. after the onset of diseases, to reduce case-fatality). Both indicators refer to premature mortality (under age 75). Please refer to the Sources and Methods for detailed country-specific information.